Borage and Echium Seed Oils for Asthma
NCT01560988 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2018-04-09
Summary
This study plans to look at whether borage and echium seed oils (natural oils from two plants) help decrease asthma symptoms and affect cells involved in inflammation. The investigators also want to look at how these plant oils decrease the generation of inflammatory cells in people with asthma.
Conditions
Interventions
- DRUG
-
Borage and Echium Seed Oils
4.0 g/day borage seed oil and 7.0 g/day echium seed oil. Pills will be taken three times per day for six weeks.
- DIETARY_SUPPLEMENT
-
Corn oil pills
Corn oils pills will be taken three times per day for six weeks.
Sponsors & Collaborators
-
Wake Forest University
collaborator OTHER -
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Joshua Boyce, MD · Brigham and Women's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- United States
Study Locations
More Related Trials
-
Plant Stanol Esters and Preventing Asthma Symptoms
NCT03983603 ·Status: RECRUITING ·Phase: NA
-
Modification of Asthma With Soy Isoflavone
NCT00741208 ·Status: COMPLETED ·Phase: NA
-
Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma.
NCT05352126 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
NCT03327701 ·Status: UNKNOWN ·Phase: PHASE3
-
The Study of Soy Isoflavones in Asthma
NCT01052116 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
NCT00581048 ·Status: COMPLETED ·Phase: NA
-
the Effect of Use of Vit d and Probiotic as a Supplementaition in the Treatment of Bronchial Asthma in Patient Aged 6 to 50 Year and Its Effect in Decrasing Excerbation.
NCT06962761 ·Status: COMPLETED
-
Evaluating Effects of Curcumin in Moderate to Severe Asthmatics
NCT04353310 ·Status: WITHDRAWN ·Phase: PHASE2
-
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
NCT00961233 ·Status: COMPLETED ·Phase: NA
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Controlled Trial of Silymarin in Asthma
NCT01049178 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma
NCT05786638 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Epigenetic Health Benefits of Budesonide
NCT04342039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Role of Herbs in the Management of Asthma
NCT02918487 ·Status: UNKNOWN ·Phase: NA
-
Presenteeism in Severe Asthma Treated by Biotherapyasthma
NCT04463589 ·Status: COMPLETED
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use
NCT06027606 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Fluticasone Furoate on Methacholine Challenge
NCT03898466 ·Status: COMPLETED ·Phase: PHASE4
-
Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With Biotherapy
NCT05972213 ·Status: RECRUITING
-
Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.
NCT01939951 ·Status: UNKNOWN ·Phase: PHASE4
-
Bosentan for Poorly Controlled Asthma
NCT00815347 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Thyme Oil in Asthmatic Patients
NCT06664671 ·Status: COMPLETED ·Phase: NA
-
Fatty Acids in Airway Smooth Muscle of Asthmatics
NCT02809235 ·Status: WITHDRAWN ·Phase: NA